Exercise in heart failure patients does not change levels of NT-proBNP [148] or cardiac troponin I [149], but chronic heart failure has a different pathophysiology than the acute effects of cardiotoxic cancer therapies. This evidence concerns the gene TNNI3 and heart failure.